Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Emissium SA

History from 2 Jun 2023

UID
CHE-465.831.014
Legal form
AG
Canton
VS
Founded
2 Jun 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 128k
32k64k96k128k17 Feb 2026 · CHF 112k19 Feb 2026 · CHF 128k
  • shares

Record

  1. SHAB published 7 Jun 2023 · legal date 2 Jun 2023

    Company formed

    Founded 2 Jun 2023

    SHAB HR01-1005763160 ↗

  2. SHAB published 17 Feb 2026 · legal date 30 Jan 2026

    Capital increase

    Capital increased

    Issued from conditional capital

    Nominal capital
    100’000 → 112’000
    Shares
    10’000’000 → 11’200’000
    New shares, % of post-step shares
    10.7% (1’200’000 new)

    Nouveau capital-actions: CHF 112'000.00 [précédemment: CHF 100'000.00]. Nouveau capital-actions libéré: CHF 62'000.00 [précédemment: CHF 50'000.00]. Nouvelles actions: 11'200'000 actions nominatives de CHF 0.01 avec restriction de transmissibilité selon statuts [précédemment: 10'000'000 actions nominatives de CHF 0.01 avec restriction de transmissibilité selon statuts].

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • Shares issued out of conditional capital, as when options are exercised.−1.0

    Classifier score 0.15 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006572523 ↗

  3. SHAB published 19 Feb 2026 · legal date 30 Jan 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    112’000 → 128’350
    Shares
    11’200’000 → 12’835’000
    New shares, % of post-step shares
    12.7% (1’635’000 new)

    Nouveau capital-actions: CHF 128'350.00 [précédemment: CHF 112'000.00]. Nouveau capital-actions libéré: CHF 78'350.00 [précédemment: CHF 62'000.00]. Nouvelles actions: 12'835'000 actions nominatives de CHF 0.01 avec restriction de transmissibilité selon statuts [précédemment: 11'200'000 actions nominatives de CHF 0.01 avec restriction de transmissibilité selon statuts]. Augmentation ordinaire du capital-actions.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006574853 ↗

Published by 8 Oct 2026